Tower Research Capital (TRC)’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-892	Closed	-$6.96K	–	6324
2023 Q3	$6.96K	Buy	+892	New	+$9.92K	﹤0.01%	4533
2023 Q2	–	Sell	-4	Closed	–	–	6491
2023 Q1	$0	Buy	+4	New	+$74	﹤0.01%	6530
2022 Q4	–	Sell	-49	Closed	-$1K	–	6605
2022 Q3	$1K	Buy	+49	New	+$1.08K	﹤0.01%	5915
2022 Q2	–	Sell	-168	Closed	-$4K	–	6744
2022 Q1	$4K	Sell	168 -35	-17%	-$697	﹤0.01%	5296
2021 Q4	$3K	Sell	203 -1,660	-89%	-$34.7K	﹤0.01%	5532
2021 Q3	$51K	Buy	+1,863	New	+$40.7K	﹤0.01%	2954

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Tower Research Capital (TRC)'s ZIVO Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 892 shares — an estimated $6.96K sold.

Tower Research Capital (TRC) first reported a position in ZIVO in Q3 2021 and held it in 6 quarters. The position peaked at $51K in Q3 2021. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 892 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $6.96K.
Tower Research Capital (TRC) first reported a position in Zivo Bioscience, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s Zivo Bioscience, Inc. Common Stock position peaked at $51K in Q3 2021.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.